Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Feb;297(2):141-155.
doi: 10.1111/joim.20038. Epub 2024 Dec 26.

Effect of an intensive lifestyle intervention on cystatin C-based kidney function in adults with overweight and obesity: From the PREDIMED-Plus trial

José Ignacio Martínez-Montoro  1   2   3   4 , Isabel Cornejo-Pareja  1   2   3   4 , Andrés Díaz-López  4   5   6 , Antoni Sureda  4   7   8 , Estefania Toledo  4   9 , Itziar Abete  4   10 , Nancy Babio  4   6   11 , Josep A Tur  4   7   8 , Miguel A Martinez-Gonzalez  4   9   12 , J Alfredo Martínez  4   10   13 , Montse Fitó  4   14 , Jordi Salas-Salvadó  4   6   11 , Francisco J Tinahones  1   2   3   4 ; PREDIMED‐Plus Investigators
Affiliations
Randomized Controlled Trial

Effect of an intensive lifestyle intervention on cystatin C-based kidney function in adults with overweight and obesity: From the PREDIMED-Plus trial

José Ignacio Martínez-Montoro et al. J Intern Med. 2025 Feb.

Abstract

Background: Large-scale trials evaluating a multicomponent lifestyle intervention aimed at weight loss on kidney function are lacking.

Methods: This was a post hoc analysis of the "PREvención con DIeta MEDiterránea-Plus" (PREDIMED-Plus) randomized controlled trial, including patients with overweight/obesity and metabolic syndrome, measured cystatin C and creatinine. Participants were randomly assigned (1:1) to an intensive weight loss lifestyle intervention (intervention group [IG]) consisting of an energy-restricted Mediterranean diet (MedDiet), physical activity promotion and behavioral support, or a control group (CG) receiving ad libitum MedDiet recommendations. The primary outcome was between-group differences in cystatin C-based kidney function (cystatin C-based estimated glomerular filtration rate-eGFRcys-and combined cystatin C-creatinine-based eGFR-eGFRcr-cys) change from baseline to 12 and 36 months. Secondary outcomes included between-group differences in creatinine-based eGFR (eGFRcr) and urinary albumin-to-creatinine ratio (UACR) change and the predictive capacity of these formulas at baseline for new-onset chronic kidney disease (CKD).

Results: A total of 1909 participants (65 ± 5 years, 54% men) were included. Twelve-month decline in eGFRcys, eGFRcr-cys, and eGFRcr was greater in the CG compared to the IG, with between-group differences of -1.77 mL/min/1.73 m2 [95% confidence interval -2.92 to -0.63], -1.37 [-2.22 to -0.53], and -0.91 [-1.74 to -0.71], respectively. At 36 months, the decline in eGFRcr-cys and eGFRcr was greater in the CG. No between-group differences in UACR were found. Significant adjusted areas under the curve for baseline eGFRcys and eGFRcr-cys were observed for incident CKD at 36 months, which were similar to those for eGFRcr and UACR.

Conclusions: In older adults with overweight/obesity and metabolic syndrome, the PREDIMED-Plus intervention may be an optimal approach to preserve kidney function.

Keywords: Mediterranean diet; cystatin C; kidney function; lifestyle intervention; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Receiver‐operating characteristic analysis for the evaluation of the predictive capacity of baseline creatinine‐based and cystatin C–based kidney function for 12‐month incident chronic kidney disease. eGFRcr‐cys, creatinine‐based and cystatin C–based estimated glomerular filtration rate; eGFRcr, creatinine‐based estimated glomerular filtration rate; eGFRcys, cystatin C–based estimated glomerular filtration rate; UACR, urinary albumin‐to‐creatinine ratio.
Fig. 2
Fig. 2
Receiver‐operating characteristic analysis for the evaluation of the predictive capacity of baseline creatinine‐based and cystatin C–based kidney function for 36‐month incident chronic kidney disease. eGFRcr‐cys, creatinine‐based and cystatin C–based estimated glomerular filtration rate; eGFRcr, creatinine‐based estimated glomerular filtration rate; eGFRcys, cystatin C–based estimated glomerular filtration rate; UACR, urinary albumin‐to‐creatinine ratio.
See this image and copyright information in PMC

Similar articles

  • Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
    Salas-Salvadó J, Díaz-López A, Ruiz-Canela M, Basora J, Fitó M, Corella D, Serra-Majem L, Wärnberg J, Romaguera D, Estruch R, Vidal J, Martínez JA, Arós F, Vázquez C, Ros E, Vioque J, López-Miranda J, Bueno-Cavanillas A, Tur JA, Tinahones FJ, Martín V, Lapetra J, Pintó X, Daimiel L, Delgado-Rodríguez M, Matía P, Gómez-Gracia E, Díez-Espino J, Babio N, Castañer O, Sorlí JV, Fiol M, Zulet MÁ, Bulló M, Goday A, Martínez-González MÁ; PREDIMED-Plus investigators. Salas-Salvadó J, et al. Diabetes Care. 2019 May;42(5):777-788. doi: 10.2337/dc18-0836. Epub 2018 Nov 2. Diabetes Care. 2019. PMID: 30389673 Clinical Trial.
  • Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function: A Randomized Controlled Trial.
    Díaz-López A, Becerra-Tomás N, Ruiz V, Toledo E, Babio N, Corella D, Fitó M, Romaguera D, Vioque J, Alonso-Gómez ÁM, Wärnberg J, Martínez JA, Serra-Majem L, Estruch R, Tinahones FJ, Lapetra J, Pintó X, Tur JA, López-Miranda J, Cano Ibañez N, Delgado-Rodríguez M, Matía-Martín P, Daimiel L, de Paz JA, Vidal J, Vázquez C, Ruiz-Canela M, Bulló M, Sorlí JV, Goday A, Fiol M, García-de-la-Hera M, Tojal Sierra L, Pérez-Farinós N, Zulet MÁ, Sánchez-Villegas A, Sacanella E, Fernández-García JC, Santos-Lozano JM, Gimenez-Gracia M, Del Mar Bibiloni M, Diez-Espino J, Ortega-Azorin C, Castañer O, Morey M, Torres-Collado L, Sorto Sanchez C, Muñoz MÁ, Ros E, Martinez-Gonzalez MA, Salas-Salvadó J; PREDIMED-Plus Investigators. Díaz-López A, et al. Am J Nephrol. 2021;52(1):45-58. doi: 10.1159/000513664. Epub 2021 Feb 8. Am J Nephrol. 2021. PMID: 33556935 Clinical Trial.
  • Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test.
    Fan L, Inker LA, Rossert J, Froissart M, Rossing P, Mauer M, Levey AS. Fan L, et al. Nephrol Dial Transplant. 2014 Jun;29(6):1195-203. doi: 10.1093/ndt/gft509. Epub 2014 Jan 20. Nephrol Dial Transplant. 2014. PMID: 24449101 Free PMC article.
  • Intensive Weight-Loss Lifestyle Intervention Using Mediterranean Diet and COVID-19 Risk in Older Adults: Secondary Analysis of PREDIMED-Plus Trial.
    Shyam S, García-Gavilán JF, Paz-Graniel I, Gaforio JJ, Martínez-González MÁ, Corella D, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem JL, Bueno-Cavanillas A, Tur JA, Martín Sánchez V, Pintó X, Matía-Martín P, Vidal J, Del Mar Alcarria M, Daimiel L, Ros E, Fernandez-Aranda F, Nishi SK, García-Regata Ó, Perez Araluce R, Asensio EM, Castañer O, Garcia-Rios A, Oncina-Cánovas A, Bouzas C, Zulet MA, Rayó E, Casas R, Martin-Pelaez S, Tojal-Sierra L, Bernal-López MR, Carlos S, Sorlí JV, Goday A, Peña-Orihuela PJ, Pastor-Morel A, Eguaras S, Zomeño MD, Delgado-Rodríguez M, Babio N, Fitó M, Salas-Salvadó J. Shyam S, et al. J Nutr Health Aging. 2023;27(12):1162-1167. doi: 10.1007/s12603-023-2044-4. J Nutr Health Aging. 2023. PMID: 38151866 Clinical Trial.
  • CYSTATIN C-A Monitoring Perspective of Chronic Kidney Disease in Patients with Diabetes.
    Visinescu AM, Rusu E, Cosoreanu A, Radulian G. Visinescu AM, et al. Int J Mol Sci. 2024 Jul 26;25(15):8135. doi: 10.3390/ijms25158135. Int J Mol Sci. 2024. PMID: 39125705 Free PMC article. Review.
See all similar articles

References

    1. Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–733. 10.1016/S0140-6736(20)30045-3 - DOI - PMC - PubMed
    1. Rhee CM, Kovesdy CP. Spotlight on CKD deaths—increasing mortality worldwide. Nat Rev Nephrol. 2015;11(4):199–200. 10.1038/nrneph.2015.25 - DOI - PMC - PubMed
    1. Kuma A, Kato A. Lifestyle‐related risk factors for the incidence and progression of chronic kidney disease in the healthy young and middle‐aged population. Nutrients. 2022;14(18):3787. 10.3390/nu14183787 - DOI - PMC - PubMed
    1. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S. Weight loss interventions in chronic kidney disease: a systematic review and meta‐analysis. Clin J Am Soc Nephrol. 2009;4(10):1565–1574. 10.2215/CJN.02250409 - DOI - PMC - PubMed
    1. Gong X, Zeng X, Fu P. The impact of weight loss on renal function in individuals with obesity and type 2 diabetes: a comprehensive review. Front Endocrinol (Lausanne). 2024;15:1320627. 10.3389/fendo.2024.1320627 - DOI - PMC - PubMed

Publication types

MeSH terms

Grants and funding